HomeCompareTRXPF vs NOBL

TRXPF vs NOBL: Dividend Comparison 2026

TRXPF yields 3.27% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRXPF wins by $634.91M in total portfolio value
10 years
TRXPF
TRXPF
● Live price
3.27%
Share price
$24.57
Annual div
$0.80
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$634.94M
Annual income
$599,684,359.43
Full TRXPF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — TRXPF vs NOBL

📍 TRXPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRXPFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRXPF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRXPF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXPF
Annual income on $10K today (after 15% tax)
$277.78/yr
After 10yr DRIP, annual income (after tax)
$509,731,705.52/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, TRXPF beats the other by $509,731,496.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXPF + NOBL for your $10,000?

TRXPF: 50%NOBL: 50%
100% NOBL50/50100% TRXPF
Portfolio after 10yr
$317.48M
Annual income
$299,842,302.80/yr
Blended yield
94.44%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXPF buys
0
NOBL buys
0
No recent congressional trades found for TRXPF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRXPFNOBL
Forward yield3.27%2.14%
Annual dividend / share$0.80$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$634.94M$22.8K
Annual income after 10y$599,684,359.43$246.19
Total dividends collected$632.35M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: TRXPF vs NOBL ($10,000, DRIP)

YearTRXPF PortfolioTRXPF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,354$653.59$10,914$214.34+$440.00TRXPF
2$13,535$1,387.04$11,897$218.63+$1.6KTRXPF
3$17,574$3,090.80$12,952$222.72+$4.6KTRXPF
4$26,305$7,500.82$14,086$226.62+$12.2KTRXPF
5$49,132$20,985.78$15,302$230.33+$33.8KTRXPF
6$125,837$73,265.77$16,607$233.85+$109.2KTRXPF
7$485,391$350,745.93$18,007$237.18+$467.4KTRXPF
8$3,048,220$2,528,851.81$19,508$240.35+$3.03MTRXPF
9$32,945,707$29,684,110.82$21,116$243.35+$32.92MTRXPF
10$634,936,266$599,684,359.43$22,841$246.19+$634.91MTRXPF

TRXPF vs NOBL: Complete Analysis 2026

TRXPFStock

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Full TRXPF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this TRXPF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXPF vs SCHDTRXPF vs JEPITRXPF vs OTRXPF vs KOTRXPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.